Charles Current Deferred Revenue vs Deferred Long Term Liab Analysis

CRL Stock

USD 199.59 1.84 0.93%

Charles River financial indicator trend analysis is way more than just evaluating Charles River Labora prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Charles River Labora is a good investment. Please check the relationship between Charles River Current Deferred Revenue and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Charles River Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Current Deferred Revenue vs Deferred Long Term Liab

Current Deferred Revenue vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Charles River Labora Current Deferred Revenue account and Deferred Long Term Liab. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Charles River's Current Deferred Revenue and Deferred Long Term Liab is 0.97. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Charles River Laboratories, assuming nothing else is changed. The correlation between historical values of Charles River's Current Deferred Revenue and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Charles River Laboratories are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Current Deferred Revenue i.e., Charles River's Current Deferred Revenue and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.97

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Charles River's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Charles River Labora current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Charles River Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

At this time, Charles River's Selling General Administrative is quite stable compared to the past year. Discontinued Operations is expected to rise to about 1.8 M this year, although Enterprise Value Over EBITDA will most likely fall to 9.06.

	2021	2022	2023	2024 (projected)
Interest Expense	73.9M	59.3M	136.7M	143.5M
Depreciation And Amortization	265.5M	303.9M	314.1M	329.8M

Interest Expense Depreciation And Amortization

Charles River fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock
Total Assets		0.99	1.0	0.99	0.99	0.98	0.98	0.99	0.93	0.97	0.81	1.0	0.9	0.81	0.98	-0.13	0.52	0.99	0.94	0.85	0.84	0.99	0.9	0.99	0.66	-0.19
Short Long Term Debt Total	0.99		0.99	0.99	0.97	0.98	0.98	1.0	0.89	0.98	0.83	0.99	0.86	0.83	0.98	-0.12	0.55	1.0	0.91	0.84	0.87	1.0	0.86	0.98	0.6	-0.17
Other Current Liab	1.0	0.99		0.99	0.98	0.97	0.98	0.99	0.91	0.96	0.84	0.99	0.88	0.84	0.98	-0.12	0.54	0.99	0.92	0.83	0.85	0.99	0.88	0.99	0.64	-0.17
Total Current Liabilities	0.99	0.99	0.99		0.97	0.97	0.99	0.99	0.89	0.98	0.83	0.99	0.85	0.84	0.98	-0.14	0.53	0.99	0.9	0.86	0.86	1.0	0.84	0.98	0.6	-0.18
Total Stockholder Equity	0.99	0.97	0.98	0.97		0.98	0.95	0.97	0.96	0.94	0.76	0.99	0.95	0.76	0.96	-0.14	0.47	0.97	0.97	0.85	0.78	0.97	0.94	0.98	0.75	-0.2
Property Plant And Equipment Net	0.98	0.98	0.97	0.97	0.98		0.94	0.97	0.9	0.94	0.78	0.98	0.92	0.78	0.96	-0.02	0.6	0.97	0.96	0.88	0.84	0.97	0.93	0.98	0.72	-0.07
Current Deferred Revenue	0.98	0.98	0.98	0.99	0.95	0.94		0.98	0.9	0.97	0.82	0.98	0.82	0.82	0.98	-0.18	0.48	0.99	0.88	0.81	0.84	0.99	0.82	0.97	0.56	-0.23
Net Debt	0.99	1.0	0.99	0.99	0.97	0.97	0.98		0.9	0.98	0.81	0.99	0.86	0.82	0.98	-0.13	0.54	1.0	0.91	0.84	0.86	1.0	0.86	0.98	0.6	-0.18
Retained Earnings	0.93	0.89	0.91	0.89	0.96	0.9	0.9	0.9		0.89	0.62	0.93	0.92	0.63	0.89	-0.25	0.25	0.89	0.94	0.76	0.6	0.89	0.91	0.9	0.76	-0.3
Accounts Payable	0.97	0.98	0.96	0.98	0.94	0.94	0.97	0.98	0.89		0.79	0.97	0.8	0.79	0.95	-0.18	0.46	0.98	0.85	0.86	0.82	0.98	0.79	0.94	0.51	-0.22
Cash	0.81	0.83	0.84	0.83	0.76	0.78	0.82	0.81	0.62	0.79		0.8	0.61	1.0	0.85	-0.03	0.6	0.83	0.67	0.7	0.92	0.83	0.61	0.84	0.36	-0.06
Non Current Assets Total	1.0	0.99	0.99	0.99	0.99	0.98	0.98	0.99	0.93	0.97	0.8		0.9	0.8	0.98	-0.15	0.5	0.99	0.94	0.85	0.83	0.99	0.89	0.98	0.66	-0.21
Non Currrent Assets Other	0.9	0.86	0.88	0.85	0.95	0.92	0.82	0.86	0.92	0.8	0.61	0.9		0.61	0.85	-0.07	0.42	0.85	0.99	0.78	0.63	0.85	0.99	0.89	0.9	-0.14
Cash And Short Term Investments	0.81	0.83	0.84	0.84	0.76	0.78	0.82	0.82	0.63	0.79	1.0	0.8	0.61		0.85	-0.03	0.6	0.84	0.68	0.7	0.92	0.84	0.62	0.85	0.36	-0.06
Net Receivables	0.98	0.98	0.98	0.98	0.96	0.96	0.98	0.98	0.89	0.95	0.85	0.98	0.85	0.85		-0.06	0.58	0.99	0.91	0.82	0.86	0.99	0.86	0.99	0.62	-0.11
Common Stock Total Equity	-0.13	-0.12	-0.12	-0.14	-0.14	-0.02	-0.18	-0.13	-0.25	-0.18	-0.03	-0.15	-0.07	-0.03	-0.06		0.68	-0.13	-0.05	0.03	0.03	-0.13	0.0	-0.04	0.04	1.0
Common Stock Shares Outstanding	0.52	0.55	0.54	0.53	0.47	0.6	0.48	0.54	0.25	0.46	0.6	0.5	0.42	0.6	0.58	0.68		0.55	0.48	0.56	0.72	0.54	0.47	0.59	0.31	0.65
Non Current Liabilities Total	0.99	1.0	0.99	0.99	0.97	0.97	0.99	1.0	0.89	0.98	0.83	0.99	0.85	0.84	0.99	-0.13	0.55		0.9	0.84	0.87	1.0	0.85	0.98	0.59	-0.17
Inventory	0.94	0.91	0.92	0.9	0.97	0.96	0.88	0.91	0.94	0.85	0.67	0.94	0.99	0.68	0.91	-0.05	0.48	0.9		0.79	0.7	0.9	0.99	0.94	0.87	-0.12
Other Current Assets	0.85	0.84	0.83	0.86	0.85	0.88	0.81	0.84	0.76	0.86	0.7	0.85	0.78	0.7	0.82	0.03	0.56	0.84	0.79		0.76	0.84	0.74	0.85	0.53	0.0
Other Stockholder Equity	0.84	0.87	0.85	0.86	0.78	0.84	0.84	0.86	0.6	0.82	0.92	0.83	0.63	0.92	0.86	0.03	0.72	0.87	0.7	0.76		0.87	0.65	0.85	0.38	-0.02
Total Liab	0.99	1.0	0.99	1.0	0.97	0.97	0.99	1.0	0.89	0.98	0.83	0.99	0.85	0.84	0.99	-0.13	0.54	1.0	0.9	0.84	0.87		0.85	0.98	0.59	-0.18
Property Plant And Equipment Gross	0.9	0.86	0.88	0.84	0.94	0.93	0.82	0.86	0.91	0.79	0.61	0.89	0.99	0.62	0.86	0.0	0.47	0.85	0.99	0.74	0.65	0.85		0.9	0.91	-0.07
Total Current Assets	0.99	0.98	0.99	0.98	0.98	0.98	0.97	0.98	0.9	0.94	0.84	0.98	0.89	0.85	0.99	-0.04	0.59	0.98	0.94	0.85	0.85	0.98	0.9		0.68	-0.09
Short Term Debt	0.66	0.6	0.64	0.6	0.75	0.72	0.56	0.6	0.76	0.51	0.36	0.66	0.9	0.36	0.62	0.04	0.31	0.59	0.87	0.53	0.38	0.59	0.91	0.68		-0.03
Common Stock	-0.19	-0.17	-0.17	-0.18	-0.2	-0.07	-0.23	-0.18	-0.3	-0.22	-0.06	-0.21	-0.14	-0.06	-0.11	1.0	0.65	-0.17	-0.12	0.0	-0.02	-0.18	-0.07	-0.09	-0.03

Click cells to compare fundamentals

Charles River Account Relationship Matchups

Charles River fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.7B	5.5B	7.0B	7.6B	8.2B	8.6B
Short Long Term Debt Total	2.0B	2.1B	2.9B	3.1B	3.1B	3.2B
Other Current Liab	388.3M	409.6M	553.1M	531.3M	605.5M	635.8M
Total Current Liabilities	710.2M	839.8M	1.0B	1.1B	1.1B	1.1B
Total Stockholder Equity	1.6B	2.1B	2.5B	3.0B	3.6B	3.8B
Property Plant And Equipment Net	1.2B	1.3B	1.6B	1.9B	2.0B	2.1B
Current Deferred Revenue	171.8M	207.9M	219.7M	264.3M	241.8M	253.9M
Net Debt	1.8B	1.9B	2.7B	2.9B	2.8B	2.9B
Retained Earnings	280.3M	625.4M	980.8M	1.4B	1.9B	2.0B
Accounts Payable	111.5M	122.5M	198.1M	205.9M	168.9M	177.4M
Cash	238.0M	228.4M	241.2M	233.9M	276.8M	172.3M
Non Current Assets Total	3.7B	4.3B	5.8B	6.2B	6.6B	6.9B
Non Currrent Assets Other	89.6M	130.8M	151.5M	148.3M	309.4M	324.9M
Cash And Short Term Investments	238.0M	228.4M	241.2M	233.9M	276.8M	173.9M
Net Receivables	514.0M	617.7M	642.9M	752.4M	780.4M	819.4M
Common Stock Total Equity	489K	498K	505K	509K	585.4K	681.5K
Common Stock Shares Outstanding	49.7M	50.6M	51.4M	51.3M	51.5M	55.4M
Liabilities And Stockholders Equity	4.7B	5.5B	7.0B	7.6B	8.2B	8.6B
Non Current Liabilities Total	2.3B	2.5B	3.4B	3.5B	3.5B	3.7B
Inventory	160.7M	185.7M	199.1M	255.8M	380.3M	399.3M
Other Current Assets	56.0M	165.2M	190.9M	196.9M	171.3M	179.8M
Other Stockholder Equity	1.5B	1.6B	1.7B	1.8B	1.9B	1.3B
Total Liab	3.0B	3.3B	4.4B	4.6B	4.5B	4.8B
Property Plant And Equipment Gross	1.2B	1.1B	1.6B	1.9B	3.4B	3.5B
Total Current Assets	1.0B	1.2B	1.3B	1.4B	1.6B	1.7B
Accumulated Other Comprehensive Income	(178.0M)	(138.9M)	(164.7M)	(262.1M)	(196.4M)	(186.6M)
Short Term Debt	38.5M	74.9M	36.1M	50.2M	441.1M	463.2M
Common Stock	489K	498K	505K	509K	513K	670.0K
Intangible Assets	689.4M	787.6M	1.1B	955.3M	864.1M	480.2M
Other Liab	350.2M	422.2M	482.6M	390.4M	449.0M	471.4M
Other Assets	134.3M	1.5B	(47.2M)	1K	1.2K	1.1K
Long Term Debt	1.8B	1.9B	2.6B	2.7B	2.6B	2.8B
Good Will	1.5B	1.8B	2.7B	2.8B	3.1B	3.2B
Property Plant Equipment	1.0B	1.1B	1.6B	1.9B	2.1B	2.2B
Short Term Investments	941K	1.0M	1.1M	998K	898.2K	853.3K
Net Tangible Assets	(566.7M)	(456.7M)	(1.2B)	(786.5M)	(707.8M)	(672.4M)
Noncontrolling Interest In Consolidated Entity	3.2M	3.6M	4.2M	4.8M	5.5M	3.4M
Retained Earnings Total Equity	280.3M	625.4M	980.8M	1.4B	1.6B	1.7B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Charles River Labora is a strong investment it is important to analyze Charles River's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Charles River's future performance. For an informed investment choice regarding Charles Stock, refer to the following important reports:

How To Invest In Charles

Details

Is Charles Stock a good investment?

Details

What is Charles River's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Charles River Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Charles River. If investors know Charles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Charles River listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.21)

Earnings Share

8.01

Revenue Per Share

78.97

Quarterly Revenue Growth

(0.02)

Return On Assets

0.0487

The market value of Charles River Labora is measured differently than its book value, which is the value of Charles that is recorded on the company's balance sheet. Investors also form their own opinion of Charles River's value that differs from its market value or its book value, called intrinsic value, which is Charles River's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Charles River's market value can be influenced by many factors that don't directly affect Charles River's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Charles River's value and its price as these two are different measures arrived at by different means. Investors typically determine if Charles River is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Charles River's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Charles Current Deferred Revenue vs Deferred Long Term Liab Analysis

Current Deferred Revenue vs Deferred Long Term Liab

Current Deferred Revenue vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Deferred Long Term Liab

Charles River fundamental ratios Correlations

Charles River Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Charles River fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Current Liab	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Net Debt	+ 1.0	Short Long Term Debt Total
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Total Current Liabilities

Common Stock	- 0.3	Retained Earnings
Common Stock Total Equity	- 0.25	Retained Earnings
Common Stock	- 0.23	Current Deferred Revenue
Common Stock	- 0.22	Accounts Payable
Common Stock	- 0.21	Non Current Assets Total
Common Stock	- 0.2	Total Stockholder Equity